DecreasedC-MYCandBCL2Expression Correlates with Methylprednisolone-Mediated Inhibition of Raji Lymphoma Growth
- 1 April 1997
- journal article
- Published by Elsevier in Biochemical and Molecular Medicine
- Vol. 60 (2), 108-115
- https://doi.org/10.1006/bmme.1997.2568
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Radioimmunotherapy of Lymphoma: A UC Davis ExperienceHybridoma, 1995
- Mediation of c-Myc-Induced Apoptosis by p53Science, 1994
- Effect of lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemiaCancer, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986
- The Regulation and Expression of c-myc in Normal and Malignant CellsAnnual Review of Immunology, 1986
- Involvement of the bcl -2 Gene in Human Follicular LymphomaScience, 1985
- CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA)The Lancet, 1964